NORTHBROOK, Ill.--(BUSINESS WIRE)--Pharma Start, LLC, a contract research organization (CRO) focused on quality, strategic collaboration, and customer satisfaction for global biopharmaceutical and medical device companies, is proud to announce its successful transition reassessment to the ISO 9001:2015 standard.
“Pharma Start achieved certification to the ISO 9001:2008 standard soon after opening in 2013 as a pledge to provide high-quality services to our valued customers,” said Company Principal and President, Dr. Christina Fleming. “Successfully achieving our transition to the ISO 9001:2015 standard further demonstrates our continued commitment to build quality into our services to maximize value for our customers.”
“A fully implemented quality management system provides assurance to our customers that Pharma Start generates consistent results using controlled processes,” said Tom McGrady, Pharma Start’s Chief Compliance Officer and Vice President of Quality and Regulatory Compliance. “All employees are driven to provide the highest quality work output to meet the needs of our customers.”
About Pharma Start
Pharma Start, based in Northbrook, IL, provides strategic consulting and outsourced R&D solutions for biopharmaceutical and medical device companies with areas of expertise in preclinical assessment, translational medicine, clinical pharmacology, project management, full service clinical trial support, remote visit services, and medical / regulatory writing and submissions. For further information on Pharma Start, visit: http://www.pharma-start.com.
Bill Haynes, 617-391-0790
Last updated on: 29/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.